EORTC risk tables: Predicting recurrence and progression in stage Ta T1 bladder cancer patients.
In order to predict, separately, the short- and long-term risks of disease recurrence and progression in individual patients, the EORTC Genito-Urinary Cancer Group has developed a scoring system and risk tables.

The scoring system is based on the six most significant clinical and pathological factors. 

The EORTC tables were developed to provide an easy calculation of the estimated recurrence, and progression probabilities of bladder cancer over 1- and 5-years.
Research authors: None
Version: 1.2
  • Public
  • Oncology
  • {{ modelType }}
  • Details
  • Save input
  • Load input

Calculate the result

Set more parameters to perform the calculation
Calculating......
Calculation error. Please check the model..

Conditional information

{{ file.classification }}
PRO
Note
Notes are only visible in the result download and will not be saved by Evidencio

This model is provided for educational, training and information purposes. It must not be used to support medical decision making, or to provide medical or diagnostic services. Read our full disclaimer.

Underlying models Part of
Comments
Comment
Please enter a comment
Comments are visible to anyone

Model feedback

No feedback yet 1 Comment {{ model.comments.length }} Comments
On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
{{ comment.content }}
Evidencio v3.29 © 2015 - 2024 Evidencio. All Rights Reserved